Novo Genomics
PrivateLast Round
Seed
Apr 1, 2022
Momentum Score
25 /100
Company Overview
Novo Genomics is a biotechnology company that provides genomic and multi-omic services intended to transform healthcare through advanced analytics and data mining.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novo Genomics Comps
Public and private peers based on sector, stage, and business model.
Novo Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 1, 2022 |
Key People
Founding team and executive leadership
Novo Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Emkan Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 26, 2025
Added Propathologyofwy, a pathology startup, as a customer.
Novo Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Novo Genomics's valuation, stock price, and market status.
